Royalty Pharma

ISIN GB00BMVP7Y09

WKN A2P62D

Overview

Description

Royalty Pharma Plc fournit des services de développement de médicaments. Elle opère en tant que bailleur de fonds de l'innovation dans l'industrie biopharmaceutique, en collaborant avec des innovateurs issus d'institutions universitaires, d'hôpitaux de recherche et d'organisations à but non lucratif, en passant par des sociétés de biotechnologie de petite et moyenne capitalisation, jusqu'à des sociétés pharmaceutiques mondiales. Son portefeuille comprend des royalties, notamment Imbruvica d'AbbVie et J&J, Xtandi d'Astellas et Pfizer, Tysabri de Biogen, la franchise VIH de Gilead, Januvia de Merck, Promacta de Novartis, Kalydeco, Orkambi, Symdeko et Trikafta de Vertex, ainsi que cinq produits candidats en phase de développement. La société a été fondée par Pablo Gerardo Legorreta et Rory B. Riggs en 1996 et son siège social se trouve à New York, NY.

Show more Show less

Santé Produits biopharmaceutiques Autres produits biopharmaceutiques États-Unis

Financials

Key metrics

Market capitalisation, EUR	16 557,86 M
EPS, EUR	1,77
P/B ratio	2,09
P/E ratio	17,05
Dividend yield	2,61%

Income statement (2024)

Revenue, EUR	2 092,62 M
Net income, EUR	794,11 M
Profit margin	37,95%

What ETF is Royalty Pharma in?

There are 231 ETFs which contain Royalty Pharma. All of these ETFs are listed in the table below. The ETF with the largest weighting of Royalty Pharma is the L&G Pharma Breakthrough UCITS ETF.

Show entries

Search:

ETF	Weight	Investment focus	Fund size (in m EUR)
L&G Pharma Breakthrough UCITS ETF	3.09%	Equity World Health Care Innovation	18
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	1.43%	Equity United States Health Care Biotech	21
iShares Nasdaq US Biotechnology UCITS ETF	1.43%	Equity United States Health Care Biotech	342
Invesco Nasdaq Next Generation 100 UCITS ETF Acc	0.92%	Equity United States Technology	35
VanEck Morningstar US SMID Moat UCITS ETF A	0.77%	Equity United States Small Cap Moat	12
UBS ETF (IE) Factor MSCI USA Low Volatility UCITS ETF (USD) A-dis	0.74%	Equity United States Low Volatility/Risk Weighted	37
UBS ETF (IE) Factor MSCI USA Low Volatility UCITS ETF (hedged to EUR) A-acc	0.74%	Equity United States Low Volatility/Risk Weighted	4
Fidelity US Quality Value UCITS ETF ACC-USD	0.69%	Equity United States Multi-Factor Strategy	4
Fidelity US Quality Income UCITS ETF Acc	0.55%	Equity United States Dividend	222
Fidelity US Quality Income UCITS ETF	0.55%	Equity United States Dividend	979

Showing 1 to 10 of 231 entries

1 2 3 4 5…24

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Broker	Rating	Execution fee	Account fee
		0.00€	0.00€	View offer*

Source: justETF Research; As of 4/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.